miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer

Table 1

Analysis of the correlation between expression of miR-125b in primary gastric cancer and its clinicopathological parameters.

Viable	Cases	miR-125b
		Low	High	value
Age (years)
<60	73	40	33	0.858
≥60	53	28	25
Gender
Male	70	35	35	0.370
Female	56	33	23
Histological grade
Well and moderate	32	22	10	0.065
Poor and other	94	46	48
T stage
T1-T2	71	32	39	0.031
T3-T4	55	36	19
TNM stage
I-II	51	19	32	0.002
III-IV	75	49	26
Lymph node metastasis
Present	88	56	32	0.001
Absent	38	12	26